Clover cancels AIM listing
Thursday, 19 January, 2006
Sydney-based Clover (ASX:CLV) has applied to the London Stock Exchange to cancel its listing on the Alternative Investment Market (AIM).
The cancellation is expected to take effect from February 16.
Clover's board felt that the costs associated with maintaining a dual listing on AIM and the ASX outweighed any benefits gained and the company will not be looking to raise new capital on AIM in the foreseeable future. All shareholdings registered in the UK on AIM will be automatically transferred following the delisting and will remain tradable as ordinary shares on the ASX.
The University of Sydney formalises cervical cancer elimination partnership
The success of a cervical cancer elimination program has led to the signing of a memorandum of...
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
